JD Supra3d
Teva v. Amneal Ruling Interprets Orange Book Listing Statute, Affirms Delisting of Device Patents
On December 20, 2024, the US Court of Appeals for the Federal Circuit released its opinion in Teva Branded Pharm. Prods. R&D, Inc. v. Amneal ...
JD Supra14d
Federal Circuit: Patent Must Claim Active Ingredient for Orange Book Listing
On December 20, 2024, the U.S. Court of Appeals for the Federal Circuit issued a significant ruling in the Teva v.